|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| A61K 31/4439 | |||
| A61P 11/00 |
| (11) | Number of the document | 2398792 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10705178.1 |
| Date of filing the European patent application | 2010-02-18 | |
| (97) | Date of publication of the European application | 2011-12-28 |
| (45) | Date of publication and mention of the grant of the patent | 2014-04-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2010/050271 |
| Date | 2010-02-18 |
| (87) | Number | WO 2010/094964 |
| Date | 2010-08-26 |
| (30) | Number | Date | Country code |
| 154099 P | 2009-02-20 | US |
| (72) |
ALCARAZ, Marie-Lyne, GB
BRIGGNER, Lars-Erik, SE
KLINGSTEDT, Per, Tomas, SE
LÖNN, Hans, Roland, SE
NICKLASSON, Helena, SE
NIXON, Robert, Anthony, GB
WATTS, Andrew, James, GB
ZUBAN, Robert, SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | TOSYLATE SALT OF A 5-PYRAZOLYL-2-PYRIDONE DERIVATIVE, USEFUL IN THE TREATMENT OF COPD |
| TOSYLATE SALT OF A 5-PYRAZOLYL-2-PYRIDONE DERIVATIVE, USEFUL IN THE TREATMENT OF COPD |